Bioethics and the reinforcement of socio-technical expectations

Social Studies of Science

Volumn 40, Issue 2, 2010, Pages 163-186

  Hedgecoe, Adam ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bioethics; Pharmacogenetics; Pharmacogenomics; Regulatory capture; Socio technical expectations; Sociology of bioethics

Indexed keywords

ARTICLE; BIOETHICS; ETHICS; HUMAN; PHARMACOGENETICS; SOCIOLOGY;

BIOETHICAL ISSUES; BIOETHICS; HUMANS; PHARMACOGENETICS; SOCIOLOGY, MEDICAL;

EID: 77949319943     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312709349781     Document Type: Article

References (82)

1. Akhtar, Saghir (2002) Pharmacogenomics: Are Pharmacists Ready for Genotyped Prescribing?, Pharmaceutical Journal 268 (2 March): 296-99.
2. Anderson, W., C. Fitzgerald & P.K. Manasco (1999) Current and Future Applications of Pharmacogenomics, New Horizons: Science and Practice of Acute Medicine 7(2) (April): 262-69.
3. Bell, John (1997) Genetics Of Common Disease, Philosophical Transactions of the Royal Society of London 352: 1051-55.
4. Benatar, D. (2006) Bioethics and Health and Human Rights: A Critical View, Journal of Medical Ethics 32: 17-20.
5. Bosk, Charles L. (1999) 'Professional Ethicist Available: Logical, Secular, Friendly', Daedelus 128: 47-68.
6. Brown, Nik, Brian Rappert & Andrew Webster (eds) (2000) Contested Futures: A Sociology of Prospective Science and Technology (Aldershot: Ashgate).
7. Burke, Wylie & Bruce M. Psaty (2007) Personalized Medicine in the Era of Genomics, Journal of the American Medical Association 298(14): 1682-84.
8. Clayton, Ruth (1986) Review of What Sort of People Should There Be?, Journal of Medical Ethics 12(3): 163-64.
9. Coats, Andrew (2000) Pharmacogenomics: Hope or Hype?, International Journal of Cardiology 76: 1-3.
10. De Vries, Raymond (2003) How Can We Help? From Sociology In To Sociology Of Bioethics, Journal of Law, Medicine and Ethics 32(2): 279-92.
11. DeVries, Raymond & Peter Conrad (1998) Why Bioethics Needs Sociology, in Raymond DeVries & Janardan Subedi (eds), Bioethics and Society: Constructing the Ethical Enterprise (Upper Saddle River, NJ: Prentice Hall): 233-57.
12. Eichelbaum, Michel, Magnus Ingelman-Sundberg & William E. Evans (2006) Pharmacogenetics and Individualised Drug Therapy, Annual Review of Medicine 57: 119-37.
13. Elliott, Carl (2002) Diary, London Review of Books 24(23) (2 November): 36-37.
14. Elliott, Carl (2004) Six Problems With Pharma-funded Bioethics, Studies in the History and Philosophy of Biology & Biomedical Science 35: 125-29.
15. Elliott, Carl (2005) Adventure! Comedy! Tragedy! Robots! How Bioethicists Learned to Stop Worrying and Embrace Their Inner Cyborgs, Journal of Bioethical Inquiry 2(1): 18-23.
16. Evans, John H. (2000) A Sociological Account of the Growth of Principalism, Hastings Center Report 30: 31-38.
17. Evans, John H. (2002) Playing God?: Human Genetic Engineering and the Rationalisation of Public Bioethical Debate (Chicago: University of Chicago Press).
18. Evans, John H. (2006) Between Technocracy and Democratic Legitimation: A Proposed Compromise Position for Common Morality Public Bioethics, Journal of Medicine and Philosophy 31: 213-34.
19. Evans W.E. & M. Relling (1999) Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics, Science 286: 487-91.
20. Faunce, T.A. (2005) Will International Human Rights Subsume Medical Ethics? Intersections in the UNESCO Universal Bioethics Declaration, Journal of Medical Ethics 31: 173-78.
21. Fox, Daniel (1993) View the Second, Hastings Center Report 23 (November/December): S13.
22. Fox, Renee & Judith Swazey (2008) Observing Biethics (Oxford & New York: Oxford University Press).
23. Ginsburg G. & J. McCarthy (2001) Personalized Medicine: Revolutionizing Drug Discovery and Patient Care, Trends in Biotechnology 19(12): 491-99.
24. Glover, Jonathan (1984) What Sort of People Should There Be? (Harmondsworth: Penguin).
25. Guyer, Ruth L. & Jonathon D. Moreno (2004) Slouching Towards Policy: Lazy Bioethics and the Perils of Science Fiction, American Journal of Bioethics 4(4): W14-W17.
26. Hedgecoe Adam (2001) Schizophrenia and the Narrative of Enlightened Geneticization, Social Studies of Science 31(6): 875-911.
27. Hedgecoe, Adam M. (2003) Terminology and the Construction of Scientific Disciplines: The Case of Pharmacogenomics, Science, Technology, & Human Values 28(4): 513-37.
28. Hedgecoe, Adam M. (2004) Critical Bioethics: Beyond the Social Science Critique of Applied Ethics, Bioethics 18(2): 120-43.
29. Hedgecoe Adam M. & Paul Martin (2003) The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics, Social Studies of Science 33(3): 327-64.
30. Hoffmaster, Barry (1992) Can Ethnography Save the Life of Medical Ethics?, Social Science and Medicine 35: 1421-31.
31. Johnson J. (2003) Pharmacogenetics: Potential For Individualized Drug Therapy Through Genetics, Trends in Genetics 19(11): 660-66.
32. Jonsen, Albert (1998) The Birth of Bioethics (New York and Oxford: Oxford University Press).
33. Kahn, Jonathon (2006) Race, Pharmacogenetics And Marketing: Putting BiDil in Context, American Journal of Bioethics 6(5): W1-W5.
34. Kerr, Anne (2000) (Re)Constructing Genetic Disease: The Clinical Continuum Between Cystic Fibrosis And Male Infertility, Social Studies of Science 30(6): 847-94.
35. Kleinman, Arthur (1999) Moral Experience and Ethical Reflection: Can Ethnography Reconcile Them? A Quandary for The New Bioethics, Daedelus 128: 69-97.
36. Lau, Kit Fun & Hakan Sakul (2000) Chapter 23: Pharmacogenomics, in J. Allen (ed.), Annual Reports in Medicinal Chemistry (Elsevier): 261-69.
37. Lazarou, J., B.H. Pomeranz & P.N. Corey (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients, Journal of the American Medical Association 279(15): 1200-05.
38. Lehman Brothers (2001) The Fruits of Genomics (New York: Lehman Brothers).
39. Lewins, Frank (1998) The Development of Bioethics and the Issue of Euthanasia: Regulating, De-regulating or Re-regulating?, Journal of Sociology 34(2): 123-34.
40. Lichter J. & J. Kurth (1997) The Impact of Pharmacogenetics on the Future of Healthcare, Current Opinion in Biotechnology 8: 692-95.
41. Lindpaintner, Klaus (1999) 'Genetics in Drug Discovery and Development: Challenge and Promise of Individualizing Treatment in Common Complex Disease', British Medical Bulletin 55(2): 471-91.
42. Lindpaintner, Klaus (2003a) Pharmacogenetics and the Future of Medical Practice, Journal of Molecular Medicine 81: 141-53.
43. Lindpaintner, Klaus (2003b) Pharmacogenetics: A New - Or Not So New? - Concept In Healthcare, Geneva Papers on Risk and Insurance 28(2): 316-30.
44. Lindpaintner, K., E. Foot, M. Caulfield & I. Hall (2001) Pharmacogenetics: Focus on Pharmacodynamics, International Journal of Pharmaceutical Medicine 15: 74-82.
45. MacKenzie, Donald (1990) Inventing Accuracy: A Historical Sociology of Nuclear Missile Guidance (Cambridge, MA: MIT Press).
46. Maitland van der Zee, A.H., A. de Boer & H.G.M. Leufkens (2000) The Interface Between Pharmacoepidemiology and Pharmacogenetics, European Journal of Pharmacology 410: 121-30.
47. Mancinelli L., M. Cronin & W. Sadée (2000) Pharmacogenomics: The Promise of Personalized Medicine, AAPS PharmSci 2(1) (7 March), Article4.
48. Martin, Paul (1999) Genes as Drugs: The Social Shaping of Gene Therapy and the Reconstruction of Genetic Disease, Sociology of Health and Illness 21: 517-38.
49. Messikomer, C.M., Renee Fox & Judith P. Swazey (2001) The Presence and Influence of Religion in American Bioethics, Perspective in Biology and Medicine 44: 485-508.
50. Millstone, Eric (2000) Analysing Biotechnology's Traumas, New Genetics & Society 19(2): 119-32.
51. Moyses C. (1999) Pharmacogenetics, Genomics, Proteomics: The New Frontiers in Drug Development, International Journal of Pharmaceutical Medicine 13: 197-202.
52. Myers, Greg (1990) Making a Discovery: Narratives of Split Genes, in Christopher Nash (ed.), Narrative in Culture: The Uses of Storytelling in the Sciences, Philosophy, and Literature (London: Routledge): 102-25.
53. Myers, Greg (1991) Stories and Styles in Two Molecular Biology Review Articles, in Charles Bazerman & James Paradis (eds), Textual Dynamics of the Professions (Madison: University of Wisconsin Press): 45-75.
54. Nerlich, Brigitte & Christopher Halliday (2007) Avian Flu: The Creation of Expectations in the Interplay Between Science and the Media, Sociology of Health and Illness 29(1): 46-65.
55. Nightingale, Paul & Paul Martin (2004) The Myth of the Biotech Revolution, Trends in Biotechnology 22(11): 564-69.
56. Nuffield Council on Bioethics (2003) Pharmacogenetics: Ethical Issues (London: Nuffield Council on Bioethics).
57. Persidis A. (1998) Pharmacogenomics and Diagnostics, Nature Biotechnology 16: 791-92.
58. Persing, B.F. & D.J. Cheek (2000) Pharmacogenomics, Nursing Clinics of North America 35(4): 975-80.
59. Phillips K., D. Veenstra, E. Oren, L. Lee & W. Sadée (2001) Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review, Journal of the American Medical Association 286(18): 2270-79.
60. Piquette-Miller, M. & D.M. Grant (2007) The Art and Science of Personalized Medicine, Clinical Pharmacology and Therapeutics 81(3): 311-15.
61. Pirmohamed, Munir, S. James, S. Meakin, C. Green, A.K. Scott, T.J. Walleyet al.(2004) Adverse Drug Reactions as Cause of Admission to Hospital: Prospective Analysis of 18,820 Patients, British Medical Journal 329: 15-19.
62. Potter, Van Rensselaer (1971) Bioethics: Bridge to the Future (Englewood Cliffs, NJ: Prentice-Hall).
63. PriceWaterHouse Coopers (2005) Pharma 2005: An Industrial Revolution in R&D. Available at (accessed 3 August 2009).
64. Reich, Warren T. (1995) Introduction, in W.T. Reich (ed.), The Encyclopedia of Bioethics, revised edn (New York: Simon & Schuster Macmillan).
65. Robert, Jason Scott (2000) Schizophrenia Epigenesis, Theoretical Medicine and Bioethics 21: 191-215.
66. Roses, Allen (2000) Pharmacogenetics And Future Drug Development and Delivery, Lancet 355: 1358-61.
67. Rothstein, Mark A. (ed.) (2003) Pharmacogenomics: Social, Ethical, and Clinical Dimensions (Hoboken, NJ: Wiley & Sons).
68. Sadée, Wolfgang (1999) Pharmacogenomics, British Medical Journal. 319: 1286.
69. Salter, Brian (2007) Bioethics, Politics and the Moral Economy of Human Embryonic Stem Cell Science: The Case of The European Union's Sixth Framework Programme, New Genetics and Society 26(3): 269-88.
70. Salter, Brian & Mavis Jones (2002) Human Genetic Technologies: European Governance and the Politics of Bioethics, Nature Reviews Genetics 3(10): 808-14.
71. Salter, Brian & Mavis Jones (2005) Biobanks and Bioethics: The Politics of Legitimation, Journal of European Public Policy 12(4): 710-32.
72. Sam, Stephen (2004) Individual Response to Treatment: Is it a Valid Assumption?, British Medical Journal 23 (329) (October): 966-68.
73. Schüklenk, Udo (2006) Editorial: Ethics In Bioethics, Bioethics 20(5): iii.
74. Schüklenk Udo, David Mertz & Juliet Richters (1995) The Bioethics Tabloids: How Professional Ethicists have Fallen for the Myth of Tertiary Transmitted Heterosexual AIDS, Health Care Analysis 3(1): 27-36.
75. Sinding, Christiane (1996) Literary Genres and the Construction of Knowledge in Biology: Semantic Shifts and Scientific Change, Social Studies of Science, 26(1): 43-70.
76. Stemerding Dirk & Jaap Jelsma (1996) Compensatory Ethics for the Human Genome Project, Science as Culture 5(3): 335-51.
77. Stevens, M.L. Tina (2000) Bioethics in America: Origins and Cultural Politics (Baltimore & London: The Johns Hopkins Press).
78. Sutrop, Margit (2004) Pharmacogenetics: Ethical Issues, Bioethics 18(4): iii-viii.
79. Van Lente, Harro & Arie Rip (1998) The Rise of Membrane Technology: From Rhetorics to Social Reality, Social Studies of Science 26(2): 221-54.
80. Vaszar, L.T., G.D. Rosen & T.A. Raffin (2002) 'Pharmacogenomics and the Challenge to Privacy', Pharmacogenomics Journal 2: 144-47.
81. Williamson, Laura (2008) The Quality of Bioethics Debate: Implications for Clinical Ethics Committees, Journal of Medical Ethics 34: 357-60.
82. Wolpe, P.R. (2000) From the Bedside to Boardroom: Sociological Shifts and Bioethics, HEC Forum 12: 191-201.